S-ClassAbout S-Class
B
BMYAI Stock Diagnostic Report
Bristol-Myers Squibb Company Non-GAAP EPS of $2.04 beats by $0.44, revenue of $12.97B beats by $1.23B
Bristol-Myers Squibb reported Non-GAAP earnings per share (EPS) and revenue that exceeded expectations.
View Source Article ↗AI CATALYST SCORE90 / 100Score computed by Sentinel V12
REFERENCE PRICE$63.1Reference entry price at analysis time
01
MARKET SNAPSHOT
Key Indicators at a Glance
Major Support61.00
Near-Term Resistance65.50
02
FUNDAMENTALS
Financial & Fundamental Analysis
Bristol-Myers Squibb Company's Non-GAAP EPS was $2.04, exceeding expectations by $0.44, and revenue also achieved $12.97B, surpassing estimates by $1.23B, demonstrating strong fundamentals in terms of performance.
03
TECHNICAL VIEW
Technical Position & Response Criteria
With the RSI at 62.4 and a daily adjustment of -0.32%, a split approach near the support level is valid.
Support61.00
Resistance65.50
04
CATALYST & STRATEGY
Catalyst Analysis & Forward Strategy
Although the company recorded an earnings surprise (EPS and revenue exceeding expectations), it is characterized as a one-time event rather than a company-driven performance announcement, necessitating ongoing monitoring of the progress of the pipeline.
05
PROOF OF WORK
Analysis Point vs. Subsequent Price Action
INITIAL · At Analysis (2026-07-30)
FINAL · Current/Verified
Renders the actual stored OHLC data directly in your browser.